Themis Medicare introduces novel opioid analgesic REMITHEM in India
Themis Medicare Ltd., a Mumbai-based pharmaceutical company with a 50-year legacy, has announced the launch of REMITHEM, a novel opioid injectable analgesic, in the Indian market. This groundbreaking medication is aimed at improving anesthesia induction, immediate post-operative care, and monitored anesthesia care. REMITHEM: A New Era in Opioid Analgesics Approved first in the USA in […]
